The DOI matches its Crossref record; 297 of the 299 references it cites were found in a registry or an index.
Master Regulators of Muscle Atrophy: Role of Costamere Components
Open accessAbstract
The loss of muscle mass and force characterizes muscle atrophy in several different conditions, which share the expression of atrogenes and the activation of their transcriptional regulators. However, attempts to antagonize muscle atrophy development in different experimental contexts by targeting contributors to the atrogene pathway showed partial effects in most cases. Other master regulators might independently contribute to muscle atrophy, as suggested by our recent evidence about the co-requirement of the muscle-specific chaperone protein melusin to inhibit unloading muscle atrophy development. Furthermore, melusin and other muscle mass regulators, such as nNOS, belong to costameres, the macromolecular complexes that connect sarcolemma to myofibrils and to the extracellular matrix, in correspondence with specific sarcomeric sites. Costameres sense a mechanical load and transduce it both as lateral force and biochemical signals. Recent evidence further broadens this classic view, by revealing the crucial participation of costameres in a sarcolemmal “signaling hub” integrating mechanical and humoral stimuli, where mechanical signals are coupled with insulin and/or insulin-like growth factor stimulation to regulate muscle mass. Therefore, this review aims to enucleate available evidence concerning the early involvement of costamere components and additional putative master regulators in the development of major types of muscle atrophy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Another redox-sensitive transcription factor is nuclear factor kappa B (NF-κB), which dramatically increases muscle activity in sarcopenia, metabolic syndrome, and obesity [83, 113].”
From The critical role of oxidative stress in sarcopenic obesity (2021) · cites this paper as [113]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818 · cited 1×
“The European Working Group on Sarcopenia in Older People defines sarcopenia by the presence of low appendicular lean mass/height2 and altered muscle strength, relative to sex-specific threshold values, and presarcopenia by the presence of decreased muscle mass without impact on muscle force development and contraction…”
BackgroundThe Unfolded Protein Response: From Stress Pathway to Homeostatic Regulation
Walter, P., & Ron, D. (2011) · Science · doi:10.1126/science.1209038 · Cited by 5,924 · cited 1×
“ATF4 protein synthesis increases in response to eIF-2-alpha phosphorylation consequent to PERK activation, and regulates gene expression of the transcription factor CHOP [56].”
BackgroundNitric oxide synthases: structure, function and inhibition
ALDERTON, W. K., COOPER, C. E., & KNOWLES, R. G. (2001) · Biochemical Journal · doi:10.1042/bj3570593 · Cited by 4,110
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Sarcopenia: Aging-Related Loss of Muscle Mass and Function
Larsson, L., Degens, H., Li, M., Salviati, L., Lee, Y. I., Thompson, W., Kirkland, J. L., & Sandri, M. (2019) · Physiological Reviews · doi:10.1152/physrev.00061.2017 · Cited by 1,797 · cited 3×
“The reduced S-nitrosylation of p53, secondary to a defective shuttle of nNOS to the nucleoskeleton, results in MuRF-1 gene upregulation [77], which is among the few atrogenes involved in sarcopenia [7,26].”
BackgroundAtrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy
Gomes, M. D., Lecker, S. H., Jagoe, R. T., Navon, A., & Goldberg, A. L. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251541198 · Cited by 1,774 · cited 1×
“The pioneering studies from Bodine’s and Goldberg’s laboratories [16,17] identified key genes, whose upregulation is shared in every of these conditions and leads to muscle atrophy development (the so-called atrogenes).”
Backgroundp53 mutant mice that display early ageing-associated phenotypes
Tyner, S. D., Venkatachalam, S., Choi, J., Jones, S., Ghebranious, N., Igelmann, H., Lu, X., Soron, G., Cooper, B., Brayton, C., et al. (2002) · Nature · doi:10.1038/415045a · Cited by 1,459 · cited 1×
“Some reports suggest that chronic activation of p53 leads to premature myofiber aging associated with a significant atrophy [74,75].”
BackgroundIKKβ/NF-κB Activation Causes Severe Muscle Wasting in Mice
Cai, D., Frantz, J. D., Tawa, N. E., Melendez, P. A., Oh, B.-C., Lidov, H. G. W., Hasselgren, P.-O., Frontera, W. R., Lee, J., Glass, D. J., et al. (2004) · Cell · doi:10.1016/j.cell.2004.09.027 · Cited by 1,367
Autophagy maintains stemness by preventing senescence
García-Prat, L., Martínez-Vicente, M., Perdiguero, E., Ortet, L., Rodríguez-Ubreva, J., Rebollo, E., Ruiz-Bonilla, V., Gutarra, S., Ballestar, E., Serrano, A. L., et al. (2016) · Nature · doi:10.1038/nature16187 · Cited by 1,355
A Chemical Inhibitor of p53 That Protects Mice from the Side Effects of Cancer Therapy
Komarov, P. G., Komarova, E. A., Kondratov, R. V., Christov-Tselkov, K., Coon, J. S., Chernov, M. V., & Gudkov, A. V. (1999) · Science · doi:10.1126/science.285.5434.1733 · Cited by 1,270 · cited 1×
“In line, the muscle wasting secondary to radiation therapy can be blocked by chemical inhibition of p53 [78].”
Background
Research works printed but not linked: 1
- Choi, S. (2018). Grp94 (HSP90B1). Encyclopedia of Signaling Molecules, Springer International Publishing.
Cited by
The critical role of oxidative stress in sarcopenic obesity
Gonzalez, A., Simon, F., Achiardi, O., Vilos, C., Cabrera, D., & Cabello-Verrugio, C. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/4493817 · Cited by 79
“Another redox-sensitive transcription factor is nuclear factor kappa B (NF-κB), which dramatically increases muscle activity in sarcopenia, metabolic syndrome, and obesity [83, 113].”
BackgroundDowling, P., Gargan, S., Murphy, S., Zweyer, M., Sabir, H., Swandulla, D., & Ohlendieck, K. (2021) · Proteomes · doi:10.3390/proteomes9010009 · Cited by 56
“Dystrophin-associated nitric oxide synthase, the enzyme responsible for the production of the key signaling molecule nitric oxide, was shown to play a regulatory role in costameres [132] and is involved in muscle fatigue, muscular atrophy and certain forms of muscular dystrophy [36,133,134].”
BackgroundGenetic Insights into Primary Restrictive Cardiomyopathy
Brodehl, A., & Gerull, B. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11082094 · Cited by 47
Delivery of engineered extracellular vesicles with miR-29b editing system for muscle atrophy therapy
Chen, R., Yuan, W., Zheng, Y., Zhu, X., Jin, B., Yang, T., Yan, Y., Xu, W., Chen, H., Gao, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01508-4 · Cited by 36
Aging, Osteo-Sarcopenia, and Musculoskeletal Mechano-Transduction
Leser, J. M., Harriot, A. D., Buck, H., Ward, C. W., & Stains, J. P. (2021) · Frontiers in Rehabilitation Sciences · doi:10.3389/fresc.2021.782848 · Cited by 33
Kim, M. J., Lee, J. M., Min, K., & Choi, Y. (2023) · Journal of Muscle Research and Cell Motility · doi:10.1007/s10974-023-09643-7 · Cited by 26
“Skeletal muscle atrophy is the pathological consequence of a wide range of conditions that can result from aging, muscle disuse, microgravity, excessive hormonal stress, and intrinsically serious illness or injury (Gorza et al. 2021).”
Chronic Systemic Curcumin Administration Antagonizes Murine Sarcopenia and Presarcopenia
Gorza, L., Germinario, E., Tibaudo, L., Vitadello, M., Tusa, C., Guerra, I., Bondì, M., Salmaso, S., Caliceti, P., Vitiello, L., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222111789 · Cited by 22
“In fact, curcumin-induced maintenance of the physiological levels of this chaperone in rat unloaded muscles is required to preserve localization of active nNOS molecules at sarcolemma, within the dystrophin-glycoprotein complex at costameres, and the consequent pro-trophic effect of NO [5,12].”
BackgroundMethodInfluentialSelf-citationВасильевна, К. В., Paramonova, I. I., Vilchinskaya, N. A., Tishkova, M. V., Matchkov, V. V., Shenkman, B. S., & Krivoi, I. I. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22083920 · Cited by 22
Role of Muscle LIM Protein in Mechanotransduction Process
Germain, P., Delalande, A., & Pichon, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23179785 · Cited by 18
Chaperone Proteins: The Rising Players in Muscle Atrophy
Acquarone, D., Bertero, A., Brancaccio, M., & Sorge, M. (2024) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13659 · Cited by 13
“It should be noted that Hsp90 modulates also others signalling pathways involved in muscle wasting, such as the nNOS and the NF-κB pathways [74, 87], however to date, there are no indication for a direct contribution of Hsp90 in regulating atrophy through these signals.”
InfluentialSelf-citationVijayakumar, M., Kannappan, P., Janani, B., & Kim, C. Y. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102543 · Cited by 12
Shemer, S. (2026) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2026.111229 · Cited by 12
“A central structural module is the DGC, which connects the cytoskeleton to the extracellular matrix and integrates mechanical and metabolic cues, including insulin signaling (142, 143).”
Ishihara, H., Otani, Y., Tanaka, K., Miyajima, H., Ngo, H. X., & Fujitani, M. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-06128-w · Cited by 14
“Muscle atrophy signaling pathways have been well-documented [54], and one of the atrogenes (i.e., Fbxo32/ MAFbx32/Atrogin-1 ) was signi fi cantly activated by BTX treatment in this study.”
Cooperation between myofibril growth and costamere maturation in human cardiomyocytes
Shi, H., Wang, C., Gao, B. Z., Henderson, J. H., & Ma, Z. (2022) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2022.1049523 · Cited by 10
“accompanied by decreased expression of costamere components (Li et al., 2013; Ruoss et al., 2018; Gorza et al., 2021).”
BackgroundLv, J., Pan, Z., Chen, J., Xu, R., Wang, D., Huang, J., Yang, D., Jiang, J., Yin, X., Cheng, H., et al. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.753072 · Cited by 10
Kazan, H. H., Kasakolu, A., Koncagül, S., Ergün, M. A., John, G., Sultanov, R., Zhelankin, A. V., Semenova, E. A., Yusupov, R. A., Kulemin, N. A., et al. (2024) · Experimental Physiology · doi:10.1113/ep091992 · Cited by 10
“Accordingly,variousstimuli,suchasunloading,denervationandageing, increase the expression of TP53 and its target genes in skeletal muscle, indicating a significant role of p53 in the development of atrophy (Gorza et al., 2021).”
Gorza, L., Germinario, E., Vitadello, M., Guerra, I., Majo, F. D., Gasparella, F., Caliceti, P., Vitiello, L., & Danieli‐Betto, D. (2023) · Antioxidants · doi:10.3390/antiox12061181 · Cited by 7
“Such a localization might also favor the uncoupling of the nNOS oxidoreductase and foster the generation of nitroperoxides [53].”
Self-citationIdentifying the challenges for successful pharmacotherapeutic management of sarcopenia
Lynch, G. S. (2022) · Expert Opinion on Pharmacotherapy · doi:10.1080/14656566.2022.2076593 · Cited by 7
“In addition to the well-reported roles of the dystrophin-glycoprotein complex (DGC) in the maintenance of muscle structure and force transmission, evidence is mounting for its important anabolic and vascular-signaling roles [21].”
BackgroundDiabetes induces modifications in costameric proteins and increases cardiomyocyte stiffness
Romanelli, G., Villarreal, L., Espasandín, C., & Benech, J. C. (2024) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00273.2024 · Cited by 6
Introduction to the Special Issue “Skeletal Muscle Atrophy: Mechanisms at a Cellular Level”
Zuccaro, E., Marchioretti, C., Pirazzini, M., & Pennuto, M. (2023) · Cells · doi:10.3390/cells12030502 · Cited by 5
From aging to space: A comparative biology of skeletal muscle degeneration
Qaisar, R. (2025) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2025.168058 · Cited by 4
Villarreal, L., Fontes-Silva, M., Mendaro, L., Romanelli, G., & Benech, J. C. (2025) · Biophysical Reviews · doi:10.1007/s12551-025-01307-9 · Cited by 3
“Costameres sense a mechanical load and transduce both lateral force and biochemical signals (Gorza et al. 2021).”
Molecular and Functional Heterogeneity of Na,K-ATPase in the Skeletal Muscle
Васильевна, К. В., & Krivoi, I. I. (2021) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093021040086 · Cited by 2
Impaired muscle metabolism in the ICU: interrogating the underlying pathophysiology
Chapple, L. S., Lynch, G. S., & Rooyackers, O. (2025) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000001285 · Cited by 1
Bidirectional role of Costameres in the pathophysiology of mdx skeletal muscles
Banks, G. B., Bisset, D., & Chamberlain, J. S. (2025) · Human Molecular Genetics · doi:10.1093/hmg/ddaf127 · Cited by 1
Skeletal muscle adaptation to microgravity: how altered mechanical cues drive catabolic signaling
Singh, S., Chakraborty, S., & Shemer, S. (2026) · EMBO Reports · doi:10.1038/s44319-026-00879-1 · Cited by 1
“Reduced DGC integrity impairs these signaling pathways and can sensitize muscle fi bers to catabolic activation (Acharyya et al, 2007; Shemer, 2026; Araujo et al, 2013), even in the absence of overt mechanical injury (Gorza et al, 2021).”
Assis, V., de Andrade, R. V., Neto, I. V. D. S., Barin, F. R., Ramos, G. V., Franco, O. L., Nóbrega, O. D. T., Mesquita‐Ferrari, R. A., Malavazzi, T. C. D. S., Rosa, T. D. S., et al. (2024) · Molecular Biology Reports · doi:10.1007/s11033-024-09992-7
Chen, R., Yuan, W., Zheng, Y., Zhu, X., Jin, B., Yang, T., Yan, Y., Xu, W., Chen, H., Gao, J., et al. (2022) · Figshare · doi:10.6084/m9.figshare.20167826
Decoupling musculoskeletal integrity in microgravity: Molecular drivers and therapeutic horizons
Parkarwar, N., Dabhekar, S. V., Dwivedi, V., Taksande, B. G., Umekar, M. J., & Mangrulkar, S. V. (2026) · Life Sciences in Space Research · doi:10.1016/j.lssr.2026.04.009
Papel de ILK sobre la disfunción mitocondrial en modelos de enfermedad renal crónica y de sarcopenia
de la Serna-Soto, M. (2026) · e_Buah
Sabirova, D. E., Baltin, M. E., Vinogradova, E. B., Eremeev, A., & Baltina, T. (2026) · Pathophysiology · doi:10.3390/pathophysiology33040079
Metadata
- Authors
- Gorza, L., Sorge, M., Seclì, L., & Brancaccio, M.
- Affiliations
- University of Padua (IT)
- University of Turin (IT)
- Corresponding author
- Gorza, Luisa
- Venue
- Cells
- Publisher
- MDPI AG
- Published
- 2021-01-03
- Volume
- 10
- Issue
- 1
- Pages
- 61
- ISSN
- 2073-4409 (ISSN-L)
- PMC
- PMC7823551
- OpenAlex
- W3120265875
- Cited by
- 31
- References
- 299
- Citations by year
- 2026: 4 · 2025: 4 · 2024: 6 · 2023: 4 · 2022: 6 · 2021: 7
- FWCI
- 0.60
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cells (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Institutional Research Information System University of Turin (University of Turin) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Padua Research Archive (University of Padova) (submittedVersion, cc-by)
- Funders
- Università degli Studi di Padova (GORZ_FINA_P13_01)
- Università degli Studi di Torino (Ricerca Locale 2019)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Keywords
- muscle atrophy, costameres, neuronal nitric oxide synthase, atrogenes, mechanical signaling, muscle mass regulation, insulin signaling, insulin-like growth factor, sarcolemma, extracellular matrix, transcription factors
- MeSH terms
- Animals, Humans, Models, Biological, Muscular Atrophy, Signal Transduction, Oxidative Stress, Mechanotransduction, Cellular, Costameres
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.